Population Neuroscience: Dementia Epidemiology Serving Precision Medicine and Population Health

Mary Ganguli, Emiliano Albanese, Sudha Seshadri, David A. Bennett, Constantine G Lyketsos, Walter A. Kukull, Ingmar Skoog, Hugh C. Hendrie

Research output: Contribution to journalArticle

Abstract

Over recent decades, epidemiology has made significant contributions to our understanding of dementia, translating scientific discoveries into population health. Here, we propose reframing dementia epidemiology as "population neuroscience," blending techniques and models from contemporary neuroscience with those of epidemiology and biostatistics. On the basis of emerging evidence and newer paradigms and methods, population neuroscience will minimize the bias typical of traditional clinical research, identify the relatively homogenous subgroups that comprise the general population, and investigate broader and denser phenotypes of dementia and cognitive impairment. Long-term follow-up of sufficiently large study cohorts will allow the identification of cohort effects and critical windows of exposure. Molecular epidemiology and omics will allow us to unravel the key distinctions within and among subgroups and better understand individuals' risk profiles. Interventional epidemiology will allow us to identify the different subgroups that respond to different treatment/prevention strategies. These strategies will inform precision medicine. In addition, insights into interactions between disease biology, personal and environmental factors, and social determinants of health will allow us to measure and track disease in communities and improve population health. By placing neuroscience within a real-world context, population neuroscience can fulfill its potential to serve both precision medicine and population health.

Original languageEnglish (US)
Pages (from-to)1-9
Number of pages9
JournalAlzheimer Disease and Associated Disorders
Volume32
Issue number1
DOIs
StatePublished - Jan 1 2018

Fingerprint

Precision Medicine
Neurosciences
Dementia
Epidemiology
Health
Population
Biostatistics
Social Determinants of Health
Cohort Effect
Molecular Epidemiology
Cohort Studies
Phenotype
Research

Keywords

  • aging
  • cohort effects
  • life course epidemiology
  • molecular epidemiology
  • protective factors
  • risk factors
  • translational epidemiology
  • trends

ASJC Scopus subject areas

  • Clinical Psychology
  • Gerontology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

Population Neuroscience : Dementia Epidemiology Serving Precision Medicine and Population Health. / Ganguli, Mary; Albanese, Emiliano; Seshadri, Sudha; Bennett, David A.; Lyketsos, Constantine G; Kukull, Walter A.; Skoog, Ingmar; Hendrie, Hugh C.

In: Alzheimer Disease and Associated Disorders, Vol. 32, No. 1, 01.01.2018, p. 1-9.

Research output: Contribution to journalArticle

Ganguli, Mary ; Albanese, Emiliano ; Seshadri, Sudha ; Bennett, David A. ; Lyketsos, Constantine G ; Kukull, Walter A. ; Skoog, Ingmar ; Hendrie, Hugh C. / Population Neuroscience : Dementia Epidemiology Serving Precision Medicine and Population Health. In: Alzheimer Disease and Associated Disorders. 2018 ; Vol. 32, No. 1. pp. 1-9.
@article{ce440540d7bf46f29aeec283f6b8fb38,
title = "Population Neuroscience: Dementia Epidemiology Serving Precision Medicine and Population Health",
abstract = "Over recent decades, epidemiology has made significant contributions to our understanding of dementia, translating scientific discoveries into population health. Here, we propose reframing dementia epidemiology as {"}population neuroscience,{"} blending techniques and models from contemporary neuroscience with those of epidemiology and biostatistics. On the basis of emerging evidence and newer paradigms and methods, population neuroscience will minimize the bias typical of traditional clinical research, identify the relatively homogenous subgroups that comprise the general population, and investigate broader and denser phenotypes of dementia and cognitive impairment. Long-term follow-up of sufficiently large study cohorts will allow the identification of cohort effects and critical windows of exposure. Molecular epidemiology and omics will allow us to unravel the key distinctions within and among subgroups and better understand individuals' risk profiles. Interventional epidemiology will allow us to identify the different subgroups that respond to different treatment/prevention strategies. These strategies will inform precision medicine. In addition, insights into interactions between disease biology, personal and environmental factors, and social determinants of health will allow us to measure and track disease in communities and improve population health. By placing neuroscience within a real-world context, population neuroscience can fulfill its potential to serve both precision medicine and population health.",
keywords = "aging, cohort effects, life course epidemiology, molecular epidemiology, protective factors, risk factors, translational epidemiology, trends",
author = "Mary Ganguli and Emiliano Albanese and Sudha Seshadri and Bennett, {David A.} and Lyketsos, {Constantine G} and Kukull, {Walter A.} and Ingmar Skoog and Hendrie, {Hugh C.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1097/WAD.0000000000000237",
language = "English (US)",
volume = "32",
pages = "1--9",
journal = "Alzheimer Disease and Associated Disorders",
issn = "0893-0341",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Population Neuroscience

T2 - Dementia Epidemiology Serving Precision Medicine and Population Health

AU - Ganguli, Mary

AU - Albanese, Emiliano

AU - Seshadri, Sudha

AU - Bennett, David A.

AU - Lyketsos, Constantine G

AU - Kukull, Walter A.

AU - Skoog, Ingmar

AU - Hendrie, Hugh C.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Over recent decades, epidemiology has made significant contributions to our understanding of dementia, translating scientific discoveries into population health. Here, we propose reframing dementia epidemiology as "population neuroscience," blending techniques and models from contemporary neuroscience with those of epidemiology and biostatistics. On the basis of emerging evidence and newer paradigms and methods, population neuroscience will minimize the bias typical of traditional clinical research, identify the relatively homogenous subgroups that comprise the general population, and investigate broader and denser phenotypes of dementia and cognitive impairment. Long-term follow-up of sufficiently large study cohorts will allow the identification of cohort effects and critical windows of exposure. Molecular epidemiology and omics will allow us to unravel the key distinctions within and among subgroups and better understand individuals' risk profiles. Interventional epidemiology will allow us to identify the different subgroups that respond to different treatment/prevention strategies. These strategies will inform precision medicine. In addition, insights into interactions between disease biology, personal and environmental factors, and social determinants of health will allow us to measure and track disease in communities and improve population health. By placing neuroscience within a real-world context, population neuroscience can fulfill its potential to serve both precision medicine and population health.

AB - Over recent decades, epidemiology has made significant contributions to our understanding of dementia, translating scientific discoveries into population health. Here, we propose reframing dementia epidemiology as "population neuroscience," blending techniques and models from contemporary neuroscience with those of epidemiology and biostatistics. On the basis of emerging evidence and newer paradigms and methods, population neuroscience will minimize the bias typical of traditional clinical research, identify the relatively homogenous subgroups that comprise the general population, and investigate broader and denser phenotypes of dementia and cognitive impairment. Long-term follow-up of sufficiently large study cohorts will allow the identification of cohort effects and critical windows of exposure. Molecular epidemiology and omics will allow us to unravel the key distinctions within and among subgroups and better understand individuals' risk profiles. Interventional epidemiology will allow us to identify the different subgroups that respond to different treatment/prevention strategies. These strategies will inform precision medicine. In addition, insights into interactions between disease biology, personal and environmental factors, and social determinants of health will allow us to measure and track disease in communities and improve population health. By placing neuroscience within a real-world context, population neuroscience can fulfill its potential to serve both precision medicine and population health.

KW - aging

KW - cohort effects

KW - life course epidemiology

KW - molecular epidemiology

KW - protective factors

KW - risk factors

KW - translational epidemiology

KW - trends

UR - http://www.scopus.com/inward/record.url?scp=85044294690&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044294690&partnerID=8YFLogxK

U2 - 10.1097/WAD.0000000000000237

DO - 10.1097/WAD.0000000000000237

M3 - Article

C2 - 29319603

AN - SCOPUS:85044294690

VL - 32

SP - 1

EP - 9

JO - Alzheimer Disease and Associated Disorders

JF - Alzheimer Disease and Associated Disorders

SN - 0893-0341

IS - 1

ER -